Skip to content

Return Participant Data


Clinical trial participants would like more data returned to them during and after participation in clinical trials; however, the frequency, timing and type of data returned to participants today is varied and inconsistent. This opportunity provides participants with the option of receiving their study data / results in the format and at the time they choose.

Considerations to Help Action the Opportunity

  • Address individual participant data return  issues early in the clinical development planning process 
  • Ensure security of participant privacy, confidentiality, flexibility and safety while maintaining scientific integrity and product approval timelines
  • Prioritize and personalize optionality in delivery and content as best as possible 
  • Provide support to sites, HCPs, participants and their care partners regarding management of individual data to optimize access, inclusiveness and health equity
  • Understand how digital technologies and existing cross collaborations can be optimized to facilitate interoperability of systems which collect and manage patient / participant clinical care and clinical research data

Value and Potential Benefits

  • Demonstrates respect and gratitude for the participant’s contributions to scientific advancements in research and development
  • Enhances patient partnerships and autonomy
  • Informs patients and increases awareness about clinical trials and enhances public trust, fairness and transparency 
  • Improves clinical trial engagement and the participant experience, potentially facilitating recruitment and retention
  • Utilizes a proactive approach to achieve operational efficiencies by being prepared for unplanned requests for individual data
  • Empowers participants to be more active decision makers when it comes to the use of the data they contribute to improve health outcomes
  • Reduces the burden on participants and health systems by reducing repeated testing / exams, where possible

Related Blog Posts

Inspiring Inclusion: The Power of Pivotal Moments 

This year, TransCelerate honored International Women’s Day, and the theme of “inspiring inclusivity” by gathering a panel of distinguished thought leaders within biopharma R&D for a discussion on “Inspiring Inclusion: The Power of Pivotal Moments.”  TransCelerate COO Allison Cuff Shimooka moderated the event. Panelists were Esther Krofah (Milken Institute Health), Joni Rutter (NCATS/NIH), Janet Woodcock…

SCOPE Summit 2024: Modernizing and Personalizing Clinical Trials  

SCOPE 2024 kicked off with 4,000 attendees traveling to Orlando, Florida, for the much-anticipated event. Common themes shared across all sessions include the importance of collaboration, focusing on patients and their caregivers, and avoiding a “one size fits all” approach to designing clinical trials. Read on for the highlights from TransCelerate’s seven sessions.   The conference…